| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |